Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic

Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions.

And they could soon be closer to receiving approval from the US Food and Drug Administration.